NCT02660489View on ClinicalTrials.gov

Effect of OC459 on the Response to Rhinovirus Challenge in Asthma

PHASE2CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

February 28, 2018

Study Completion Date

February 28, 2018

Conditions
AsthmaRhinovirusPicornaviridae InfectionsCommon Cold
Interventions
DRUG

OC459

DRUG

Placebo

OTHER

Rhinovirus

Inoculation with rhinovirus serotype 16

Trial Locations (1)

W2 1PG

St Mary's Hospital, London

Sponsors
All Listed Sponsors
collaborator

Medical Research Council

OTHER_GOV

collaborator

Atopix Therapeutics, Ltd.

INDUSTRY

lead

Imperial College London

OTHER

NCT02660489 - Effect of OC459 on the Response to Rhinovirus Challenge in Asthma | Biotech Hunter | Biotech Hunter